We have examined the binding of luzopeptin, an antitumour antibiotic, to five DNA fragments of varying base composition. The drug forms a tight, possibly covalent, complex with the DNA causing a reduction in mobility on nondenaturing polyacrylamide gels and some smearing of the bands consistent with intramolecular cross-linking of DNA duplexes. DNAaseI and micrococcal nuclease footprinting experiments suggest that the drug binds best to regions containing alternating A and T residues, although no consensus di-or trinucleotide sequence emerges. Binding to other sites is not excluded and at moderate ligand concentrations the DNA is almost totally protected from enzyme attack. Ligand-induced enhancement of DNAaseI cleavage is observed at both AT and GC-rich regions. The sequence selectivity and characteristics of luzopeptin binding are quite different from those of echinomycin, a bifunctional intercalator of related structure.
INTRODUCTION
The luzopeptins (formerly known as BBM 928) are a novel class of antitumour antibiotics containing two substituted quinoline chromophores linked by a cyclic decadepsipeptide Cl,2J. Luzopeptin A (Figure 1 ) diplays significant antitumour acivity in a variety of experimental animal tumour systems (33. These antibiotics are closely related to the quinoxaline family, which includes echinomycin and triostin [4) , although there are several significant structural differences: the luzopeptins have ten amino acids in the cyclic peptide as opposed to eight in the quinoxaline family, two of which are an unusual cyclic imino acid possessing a tetrahydropyridazine moiety, their quinoline chromophores are substituted with both methoxy and hydroxyl groups, and they lack a sulphur-containing cross-bridge. into DNA with one binding site for every five or six base-pairs [1, 5) . However, unlike most other bisintercalators it has been reported to form cross-links between DNA duplexes £6). In another contrast to the quinoxaline family luzopeptin binds strongly to both denatured DNA and RNA £13.
X-ray crystallographic studies have provided details of the three dimensional shape of luzopeptin £7]. The overall structure is similar to that of triostin and echinomycin [8£, characterised by a right-handed twist with twofold symmetry. As a consequence of the stereochemistry about the D-serine residues the quinoline chromophores can be aligned in parallel planes orthogonal to the plane of the peptide ring in an appropriate configuration for bifunctional intercalation. Based on this model the interchromophore distance can range from 1.20-1.45nm, which suggests that the molecule could easily span three base pairs, consistent with the binding data if there is neighbouring site exclusion between adjacent bound ligands.
It has been shown that echinomycin binds to GC-rich regions in DNA C9), and recent footprinting studies have confirmed that it binds preferentially to sequences containing the dinucleotide step CpG t10,11 
DNA fragments
The 160 base pair tyrT and 166 base pair pTyr2 DNA fragments were prepared and labelled at their 3 ends as previously described 1133. The 135 and 220 base pair DNA fragments were isolated from plasmid pXbsl E143 by digestion with restriction enzyme HindIII, labelling with cE 2P3 dATP using reverse transcriptase, and subsequent digestion with Sau3A. The radiolabelled fragments were separated on a 6%. polyacrylamide gel. The 320 base pair fragment was similarly obtained from plasmid pBR322; it contains the sequence from the HindIII site (position 29) to the Sau3A site at position 349, and was selectively labelled witho {3zP3 at the 3 end of the HindIll site.
Footprinting
DNAaseI footprinting was performed as previously described C13). In several instances the enzyme concentration required to produce a cleavage pattern was larger in the antibiotic-treated samples than in the appropriate controls; this has been noted in the text and figure legends. The protocol for micrococcal nuclease footprinting was as previously published £15).
Gel electrophoresis
The products of enzyme digestion were fractionated on polyacrylamide gels prepared in Tris-borate-EDTA buffer containing 7M urea. Gels (8% w/v) were either 40cm long and 0.3mm thick, or 55cm long and 0.2mm thick incorporating a thickness gradient in the lower portion. Gels were fixed in 10/. acetic acid, transferred to Whatman 3MM paper, dried under vacuum and subjected to autoradiography at -707C with an intensifying screen.
Densitometry
Autoradiographs of the products of DNAaseI digestion were scanned with a Joyce-Loebl Chromoscan 3 microdensitometer to produce profiles from which the relative intensity of each band was measured.
The chemical identity of digestion products was assigned by reference to dimethyl sulphate-piperidine tracks specific for guanine. Intensity data were normalised in terms of fractional cleavage (f)=A1/A* as previously described C11-13] where A, 
RESULTS
Before studying the fooprinting patterns produced by luzopeptin the effect of the antibiotic on the mobility of DNA itself was investigated. Samples of luzopeptin-treated DNA were electrophoresed on non-denaturing polyacrylamide gels to produce the results seen presented in Figure 2 .
Exposure to the ligand reduces the mobility of DNA and causes significant smearing of the bands. These changes appear within 5mins of mixing the drug and DNA, this altered mobility is not changed by longer incubation times. It seems unlikely that these effects could be caused by bisintercalation alone since echinomycin failed to alter the mobility of DNA. Attempts to reverse the effect by phenol extraction and ethanol precipitation were unsuccessful, suggesting that luzopeptin probably remains bound to the DNA by a very strong, perhaps covalent, linkage. This altered DNA mobility is consistent with some sort of intramolecular DNA cross-linking which has previously been suggested (6) , although it could simply be due to very tight DNA binding alone. Likewise, the mobility of DNA molecules in the denaturing polyacrylamide gels employed in footprinting experiments was also occasionally altered by luzopeptin treatment, evidenced by a diffuse band running behind the undigested material. Significantly, the mobility of the shorter DNA fragments produced by enzyme digestion was unaffected. The appearance of molecules with anomalous mobility was however abolished by carefully boiling the samples in solutions containing 1mM NaOH before electrophoresis, and this was therefore included in the enzyme stop solution in all footprinting experiments. DNAase I footprinting Typical DNAaseI digestion patterns for the upper and lower strands of the tyrT DNA fragment in the presence of luzopeptins or echinomycin are shown in Figure 3 . It is immediately apparent that the luzopeptins alter the digestion pattern in a concentration-dependent fashion and that the results obtained are very different from those seen with echinomycin.
In the presence of 20)PM luzopeptin there is widespread protection against cleavage, with few bands remaining visible, suggesting that the ligand is able to bind to many sites along the DNA. With 2 and 5uM antibiotic the pattern is intermediate between the control and 20M. At 2yM ligand no blockage sites can be identified, although the cleavage pattern is altered relative to that in the control, witness the enhancements at positions 28 and 47 ( Figure  3a) . The digestion patterns observed in the presence of luzopeptins B and C are similar those seen with luzopeptin A except that B and C appear to afford more efficient protection.
The pattern produced by 5 PM luzopeptin C is characterised by the widespread protection comparable to the effect of 20P M luzopeptin A, so that in the autoradiograph presented in Figure   3b little enzyme cutting can be seen. Each gel lane contains about 100 reasonably well resolved bands which were analysed as described in the Methods section. The results for both strands are presented in the form of a differential cleavage plot in Figure 4 . Six major protected regions can be discerned, located around positions 20, 65, 88, 117, 126, and 135. The size of these protected sites varies from 4 to 12 bases, although the latter (around position 65) could well represent two overlapping binding sites. On searching for a base sequence common to all the protected regions it is noticeable that all are close to the dinucleotide step TpA, although not all such steps are protected. Luzopeptin-enhanced sites of cleavage are also apparent in certain regions, most notably around positions 28 and 47, both of which contain oligomeric runs of A and T. Enhancement of cleavage at these sites has previously been observed with both echinomycin and actinomycin D E11,16J.
In order to clarify and extend these observations similar DNAaseI footprinting experiments were performed with luzopeptin A using four other DNA fragments. Footprinting patterns for both labelled strands of pTyr2 DNA are shown in Figure 5 along with the corresponding differential cleavage plot in Figure 6 . Further differential cleavage plots determined with the 135mer, 220mer and 320mer DNA fragments are presented in Figure 7 . With pTyr2 DNA the pattern produced by luzopeptin is again very different from that seen with echinomycin: three major regions are protected from cleavage centred around positions 72,85 and 122. A possible fourth site can be discerned near position 36 on the lower strand. All of these binding sites are close to the dinucleotide step TpA. A pronounced enhancement is apparent in the run of A and T nucleotides around position 62. The 220mer contains at least five well-resolved binding sites 
DISCUSSION
The results presented in this paper demonstrate that luzopeptin binds to DNA in a sequence-selective fashion and that its recognition properties are very different from those of the related antibiotic echinomycin. Before considering the nature of the preferred binding sites for luzopeptin we will first discuss the mode of binding of this antibiotic, since this will have implications for the interpretation of the footprinting patterns.
Mode of binding
The observations which led to the experiment of Figure 2 . confirm the previous suggestions that luzopeptin does not behave as a conventional bisintercalator (63. The reduced mobility of antibiotic-treated DNA fragments and the smearing of DNA bands are effects peculiar to luzopeptin and must somehow reflect the way in which this ligand is bound to the DNA. The altered mobility could arise either from some form of cross-linking between DNA molecules or merely from very tight bisintercalation causing an increase in the length and rigidity of the DNA. Echinomycin does not cause any such retardation, but this could be simply because the antibiotic dissociates from the DNA during the running of the gel. The observation that the retarded DNA band is smeared on the gel could again be explained in two so that such a simple interpretation is ruled out. The actual state of affairs is likely to be even more complicated if the suggestion is true that luzopeptin may possess more than one binding mode. Intermolecular cross-linking of DNA strands would also be expected to produce long protected regions since enzyme cleavage will be blocked not only by the offending ligand but also by the second opposing double-stranded DNA molecule. In this context it is worth noting that at the highest drug concentrations employed (20,yM) almost no cleavage of the DNA was detected. This behaviour distinguishes luzopeptin from echinomycin which induces a specific pattern of protection in an all-or-none fashion (11) in which no protection is visible below 5uM echinomycin, and the pattern of cleavage remains constant above lOuM ligand. The dramatic change in luzopeptin footprinting pattern over such a narrow range of antibiotic concentration argues in favour of a cross-linking reaction rather than sequence-specific binding to different sites which are occupied according to their relative affinities. Alternatively it is possible that this arises from a longe range drug-induced change in DNA conformation.
What then are the sequence recognition characteristics of this ligand? It appears that luzopeptin does not possess any absolute sequence binding requirements although regions protected from enzyme attack are generally rich in A and T residues. Runs of contiguous A or T nucleotides do not constitute good binding sites and often appear as regions of enhanced cleavage. The results with micrococcal nuclease on the tyrT fragment confirm that the apparent binding sites are real and are not merely an artefact of using DNAaseI. A more precise definition of the antibiotic binding site(s) on DNA must await more information concerning the precise structure of the luzopeptin-DNA complex (or complexes) by X-ray crystallography or NMR.
Structural changes
A common feature of sequence-selective drug binding to DNA is the occurrence of enhanced enzyme cleavage in regions surrounding some of the ligand binding sites. Echinomycin, actinomycin and nogalamycin induce distinct patterns of enhanced DNAase I cleavage which are located in runs of A and T nucleotides [11, 13, 163 whereas antibiotics of the distamycin group produce enhancements in GC-rich regions £16). Binding of luzopeptin produces unusual results in that on different DNA fragments strong DNAaseI enhancements are found in both AT-rich and GC-rich regions. This is unexpected since enhancement of cutting at AT-rich regions has previously been interpreted as resulting from a local widening of the DNA minor groove whereas enhancement at GC residues is thought to arise from narrowing the minor groove.
How can luzopeptin do both? This apparent contradiction may be taken as further evidence that luzopeptin has more than one binding mode and perhaps can intercalate from either the major or the minor helical grooves.
It is worth noting that the three clearest examples of luzopeptin-induced enhancement in GC-rich regions (positions 745 and 765 on the 220mer and position 100 on the 135mer) are adjacent to, and presumably induced by, antibiotic binding sites which are not conspicuously AT-rich (AGTC, ACAG and ACTC respctively). It is tempting to speculate that when the antibiotic binds to an AT-rich region it causes a local helical distortion rendering neighbouring homopolymeric runs of A and T more susceptible to cleavage, whereas binding to other sites causes the opposite structural effect and facilitates cleavage in GC-rich tracts. 
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